Skip to main navigation
Skip to main content
Skip to Footer
Google Tag Manager
UK
Novartis Site Directory
Our Work
Clinical Trials
Disease Areas
Novartis in the UK
Partnerships
Sponsorships
External Funding
For UK Healthcare Professionals
About Us
Who We Are
Patient group partnership
Corporate Responsibility
Patients & Caregivers
Contact Us
News
UK News Archive
Stories
Novartis UK Press Office
Careers
Our People and Culture
Future Talent Programme
Career Search
Search
UK News Archive
The UK News Archive contains resources intended for journalists only.
Advanced Search
Basic Search
From Date:
To Date:
Show:
All
Media Releases
Stories
Filter By
2021
September
Media Release
/
Sep 06, 2021
NICE recommends Novartis Cosentyx® (secukinumab) for children and young people with moderate to severe psoriasis
Read More
Media Release
/
Sep 01, 2021
World-first agreement between Novartis and the NHS enables broad and rapid access to first-in-class cholesterol-lowering medicine Leqvio® ▼(inclisiran)
Read More
Media Release
/
Sep 01, 2021
World-first agreement between Novartis and the NHS enables broad and rapid access to first-in-class cholesterol-lowering medicine Leqvio®▼ (inclisiran) across England
Read More
August
Media Release
/
Aug 19, 2021
Novartis’ Rydapt ®▼ (midostaurin) is the first and only treatment to receive NICE recommendation for routine funding for patients in England and Wales living with advanced systemic mastocytosis (AdvSM)
Read More
July
Media Release
/
Jul 26, 2021
Numbers that Matter report from Novartis reveals true burden of immune thrombocytopenia (ITP) and the impact of fatigue on UK patients’ quality of life
Read More
Media Release
/
Jul 13, 2021
Novartis BIOME UK announces selection for the HealthHub 21 Challenge, in collaboration with KQ Labs and LifeArc
Read More
Media Release
/
Jul 12, 2021
The Scottish Medicines Consortium recommends Novartis’ Kesimpta®▼ (ofatumumab) for patients living with relapsing remitting multiple sclerosis (RRMS)
Read More
June
Media Release
/
Jun 17, 2021
Novartis Cosentyx® (secukinumab) recommended by NICE for adults with non-radiographic axial spondyloarthritis (nr-axSpA)
Read More
Media Release
/
Jun 04, 2021
Novartis continues to push the boundaries of innovation, reimagining medicine, with bold science as it today unveils strong presence at ASCO, including overall survival data in prostate and breast cancer
Read More
April
Media Release
/
Apr 21, 2021
NICE recommends Novartis’ Kesimpta®▼ (ofatumumab) for patients living with relapsing remitting multiple sclerosis (RRMS)
Read More
Search Results Navigation
Current page
1
of 4
Page
2
of 4
Page
3
of 4
Page
4
of 4
Next page
next ›
Last page
last »
Related Links
General Privacy Notice for Suppliers
General Privacy Notice for Business Partners
St George's University Hospitals NHS Foundation Trust
ITP Patient Resources
You are here
Home
›
News
